Global Insulin Pumps Market 2014-2018 is the new research report available at ReportsnReports.com
Dallas, TX -- (SBWIRE) -- 12/04/2013 -- Electronic insulin pumps are fast becoming popular, effective, and preferred over traditional treatment methods for diabetes. As insulin pumps have recently come into prominence, new generations are beginning to see insulin pumps as a normal, conventional, and overall easier way to treat diabetes and are gaining patient acceptance. The pump allows blood sugar calculations to be done electronically and automatically, and presents less of a concern over constantly monitoring with a handheld device. In addition, the pump allows the user to eat and sleep comfortably because of its regulatory features. Thus, the use of insulin pumps has certainly made life easier for those using them.
Analysts forecast the Global Insulin Pumps market (http://www.reportsnreports.com/reports/271321-global-insulin-pumps-market-2014-2018.html) to grow at a CAGR of 7.78 percent over the period 2014-2018. According to the report, one of the main drivers in this market is the increase in the diabetic population globally. Various factors responsible for diabetes include smoking, alcohol, obesity, and hypertension. The increase in the prevalence of diabetes and the high market potential of diabetes products has encouraged various companies to explore the Global Insulin Pumps market.
Further, the report states that one of the major challenges faced by the market is the increase in the use of CAM. CAMs are cheaper alternatives to conventional medical care and their use is gaining prominence across the world.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=271321. Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=271321.
The report recognizes the following companies as the key players in the Global Insulin Pumps Market: Animas Corp., F. Hoffmann La Roche Ltd., Insulet Corp., and Medtronic Inc.
Other vendors mentioned in the report are Sooil Development Co. Ltd., and Tandem Diabetes Care Inc.
Global Insulin Antidiabetics Market 2012-2016 (http://www.reportsnreports.com/reports/224123-global-insulin-antidiabetics-market-2012-2016.html): Analysts forecast the Global Insulin Antidiabetics Market 2012-2016 to grow at a CAGR of 12.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Insulin Antidiabetics market has also been witnessing the trend of an increase in awareness and education. However, the increase in use of complementary and alternative medicine could pose a challenge to the growth of this market. Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=224123.
The Global Insulin Antidiabetics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Global Insulin Antidiabetics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Novo Nordisk A/S, Sanofi S.A, and Eli Lilly and Co.
Inquiry Before Buying on this Report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=224123
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)